110 related articles for article (PubMed ID: 1659463)
1. Pharmacological modulation of PAF: a therapeutic approach to endotoxin shock.
Sánchez Crespo M; Fernández-Gallardo S
J Lipid Mediat; 1991; 4(2):127-43. PubMed ID: 1659463
[No Abstract] [Full Text] [Related]
2. [Platelet-activating factor (PAF) receptor-related pathophysiology].
Ishii S; Shimizu T
Tanpakushitsu Kakusan Koso; 1999 Jun; 44(8 Suppl):1068-74. PubMed ID: 10396985
[No Abstract] [Full Text] [Related]
3. Beneficial effects of (RS)-2-methoxy-3-(octadecylcarbamoyloxy)propyl 2-(3-thiazolio)ethyl phosphate, a specific PAF antagonist, in endotoxin and anaphylactic shock.
Terashita Z; Imura Y; Nishikawa K; Sumida S
Adv Prostaglandin Thromboxane Leukot Res; 1985; 15():715-7. PubMed ID: 3004156
[No Abstract] [Full Text] [Related]
4. Bronchial hyperreactivity, increased endotoxin lethality and melanocytic tumorigenesis in transgenic mice overexpressing platelet-activating factor receptor.
Ishii S; Nagase T; Tashiro F; Ikuta K; Sato S; Waga I; Kume K; Miyazaki J; Shimizu T
EMBO J; 1997 Jan; 16(1):133-42. PubMed ID: 9009274
[TBL] [Abstract][Full Text] [Related]
5. The role of platelet activating factor and its antagonists in shock, sepsis and multiple organ failure.
Anderson BO; Bensard DD; Harken AH
Surg Gynecol Obstet; 1991 May; 172(5):415-24. PubMed ID: 1851337
[TBL] [Abstract][Full Text] [Related]
6. Specific receptors of platelet-activating factor, receptor heterogeneity, and signal transduction mechanisms.
Hwang SB
J Lipid Mediat; 1990; 2(3-4):123-58. PubMed ID: 1966805
[TBL] [Abstract][Full Text] [Related]
7. The bioregulatory role of platelet-activating factor in intracellular processes and cell-cell interactions.
Kulikov VI; Muzya GI
Biochemistry (Mosc); 1998 Jan; 63(1):47-54. PubMed ID: 9526094
[TBL] [Abstract][Full Text] [Related]
8. Platelet and plasma platelet-activating factor in sepsis and myocardial infarction.
Graham RM; Strahan ME; Norman KW; Watkins DN; Sturm MJ; Taylor RR
J Lipid Mediat Cell Signal; 1994 Mar; 9(2):167-82. PubMed ID: 8012763
[TBL] [Abstract][Full Text] [Related]
9. Platelet-activating factor antagonists: scientific background and possible clinical applications.
Koltai M; Guinot P; Hosford D; Braquet PG
Adv Pharmacol; 1994; 28():81-167. PubMed ID: 8080821
[No Abstract] [Full Text] [Related]
10. Recent studies on icosanoids and PAF-acether modulation of some central neurosecretions in the rat.
Dray F; Gerozissis K; Fafeur V; Wisner A; Bommelaer-Bayet MC; Saadi M; Rougeot C; Tiberghien C; Junier MP
Adv Prostaglandin Thromboxane Leukot Res; 1989; 19():383-6. PubMed ID: 2546391
[No Abstract] [Full Text] [Related]
11. [Platelet activating factor--role in regulating the functional activity of the mononuclear phagocyte system].
Shebzukhov IuV; Mysiakin EB
Vopr Med Khim; 1996; 42(4):278-83. PubMed ID: 9254510
[TBL] [Abstract][Full Text] [Related]
12. Platelet-activating factor (PAF) and blastocyst-endometrial interactions.
Harper MJ; Kudolo GB; Alecozay AA; Jones MA
Prog Clin Biol Res; 1989; 294():305-15. PubMed ID: 2542988
[No Abstract] [Full Text] [Related]
13. Functional validation of platelet-activating factor receptor sites characterized biochemically by a specific and reproducible [3H]platelet-activating factor binding in human platelets.
Tahraoui L; Floch A; Cavero I
J Pharmacol Exp Ther; 1990 Mar; 252(3):1221-7. PubMed ID: 2156995
[TBL] [Abstract][Full Text] [Related]
14. [Effect of analogs and antagonists of the thrombocyte-activating factor (PAF) on blood platelet aggregation].
Lakin KM; Kulikov VI; Manevich EM; Muliar AG; Shvets VI
Farmakol Toksikol; 1988; 51(4):113-23. PubMed ID: 2847936
[No Abstract] [Full Text] [Related]
15. Occupancy of platelet receptors for platelet-activating factor in patients with septicemia.
Lopez Diez F; Nieto ML; Fernandez-Gallardo S; Gijon MA; Sanchez Crespo M
J Clin Invest; 1989 May; 83(5):1733-40. PubMed ID: 2540221
[TBL] [Abstract][Full Text] [Related]
16. Role of platelet-activating factor in reproduction: sperm function.
Roudebush WE
Asian J Androl; 2001 Jun; 3(2):81-5. PubMed ID: 11404790
[TBL] [Abstract][Full Text] [Related]
17. Biochemical and pharmacological properties of SR 27388, a dual antioxidant and PAF receptor antagonist.
Herbert JM; Fraisse L; Bachy A; Valette G; Savi P; Laplace MC; Lassalle J; Roche B; Lale A; Keane PE
J Lipid Mediat; 1993 Aug; 8(1):31-51. PubMed ID: 8257776
[TBL] [Abstract][Full Text] [Related]
18. Platelet-activating factor stimulation of tyrosine kinase and its relationship to phospholipase C in rabbit platelets: studies with genistein and monoclonal antibody to phosphotyrosine.
Dhar A; Paul AK; Shukla SD
Mol Pharmacol; 1990 Apr; 37(4):519-25. PubMed ID: 1691437
[TBL] [Abstract][Full Text] [Related]
19. Downregulation of platelet-activating factor responsiveness during maturation of human dendritic cells.
Dichmann S; Rheinen H; Panther E; Herouy Y; Czech W; Termeer C; Simon JC; Gebicke-Haerter PJ; Norgauer J
J Cell Physiol; 2000 Dec; 185(3):394-400. PubMed ID: 11056009
[TBL] [Abstract][Full Text] [Related]
20. Human corneal epithelial cell functional responses to inflammatory agents and their antagonists.
Sharif NA; Wiernas TK; Howe WE; Griffin BW; Offord EA; Pfeifer AM
Invest Ophthalmol Vis Sci; 1998 Dec; 39(13):2562-71. PubMed ID: 9856766
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
